Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases.

IF 1.8 Q3 ONCOLOGY Radiation Oncology Journal Pub Date : 2023-03-01 DOI:10.3857/roj.2022.00353
Marcus A Florez, Brian De, Bhavana V Chapman, Anussara Prayongrat, Jonathan G Thomas, Thomas H Beckham, Chenyang Wang, Debra N Yeboa, Andrew J Bishop, Tina Briere, Behrang Amini, Jing Li, Claudio E Tatsui, Laurence D Rhines, Amol J Ghia
{"title":"Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases.","authors":"Marcus A Florez,&nbsp;Brian De,&nbsp;Bhavana V Chapman,&nbsp;Anussara Prayongrat,&nbsp;Jonathan G Thomas,&nbsp;Thomas H Beckham,&nbsp;Chenyang Wang,&nbsp;Debra N Yeboa,&nbsp;Andrew J Bishop,&nbsp;Tina Briere,&nbsp;Behrang Amini,&nbsp;Jing Li,&nbsp;Claudio E Tatsui,&nbsp;Laurence D Rhines,&nbsp;Amol J Ghia","doi":"10.3857/roj.2022.00353","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>There has been limited work assessing the use of re-irradiation (re-RT) for local failure following stereotactic spinal radiosurgery (SSRS). We reviewed our institutional experience of conventionally-fractionated external beam radiation (cEBRT) for salvage therapy following SSRS local failure.</p><p><strong>Materials and methods: </strong>We performed a retrospective review of 54 patients that underwent salvage conventional re-RT at previously SSRS-treated sites. Local control following re-RT was defined as the absence of progression at the treated site as determined by magnetic resonance imaging.</p><p><strong>Results: </strong>Competing risk analysis for local failure was performed using a Fine-Gray model. The median follow-up time was 25 months and median overall survival (OS) was 16 months (95% confidence interval [CI], 10.8-24.9 months) following cEBRT re-RT. Multivariable Cox proportional-hazards analysis revealed Karnofsky performance score prior to re-RT (hazard ratio [HR] = 0.95; 95% CI, 0.93-0.98; p = 0.003) and time to local failure (HR = 0.97; 95% CI, 0.94-1.00; p = 0.04) were associated with longer OS, while male sex (HR = 3.92; 95% CI, 1.64-9.33; p = 0.002) was associated with shorter OS. Local control at 12 months was 81% (95% CI, 69.3-94.0). Competing risk multivariable regression revealed radioresistant tumors (subhazard ratio [subHR] = 0.36; 95% CI, 0.15-0.90; p = 0.028) and epidural disease (subHR = 0.31; 95% CI, 0.12-0.78; p =0.013) were associated with increased risk of local failure. At 12 months, 91% of patients maintained ambulatory function.</p><p><strong>Conclusion: </strong>Our data suggest that cEBRT following SSRS local failure can be used safely and effectively. Further investigation is needed into optimal patient selection for cEBRT in the retreatment setting.</p>","PeriodicalId":46572,"journal":{"name":"Radiation Oncology Journal","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0a/58/roj-2022-00353.PMC10073838.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiation Oncology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3857/roj.2022.00353","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Purpose: There has been limited work assessing the use of re-irradiation (re-RT) for local failure following stereotactic spinal radiosurgery (SSRS). We reviewed our institutional experience of conventionally-fractionated external beam radiation (cEBRT) for salvage therapy following SSRS local failure.

Materials and methods: We performed a retrospective review of 54 patients that underwent salvage conventional re-RT at previously SSRS-treated sites. Local control following re-RT was defined as the absence of progression at the treated site as determined by magnetic resonance imaging.

Results: Competing risk analysis for local failure was performed using a Fine-Gray model. The median follow-up time was 25 months and median overall survival (OS) was 16 months (95% confidence interval [CI], 10.8-24.9 months) following cEBRT re-RT. Multivariable Cox proportional-hazards analysis revealed Karnofsky performance score prior to re-RT (hazard ratio [HR] = 0.95; 95% CI, 0.93-0.98; p = 0.003) and time to local failure (HR = 0.97; 95% CI, 0.94-1.00; p = 0.04) were associated with longer OS, while male sex (HR = 3.92; 95% CI, 1.64-9.33; p = 0.002) was associated with shorter OS. Local control at 12 months was 81% (95% CI, 69.3-94.0). Competing risk multivariable regression revealed radioresistant tumors (subhazard ratio [subHR] = 0.36; 95% CI, 0.15-0.90; p = 0.028) and epidural disease (subHR = 0.31; 95% CI, 0.12-0.78; p =0.013) were associated with increased risk of local failure. At 12 months, 91% of patients maintained ambulatory function.

Conclusion: Our data suggest that cEBRT following SSRS local failure can be used safely and effectively. Further investigation is needed into optimal patient selection for cEBRT in the retreatment setting.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
脊柱转移瘤立体定向放射手术后补救性常规再照射的安全性和有效性。
目的:对于立体定向脊柱放射手术(SSRS)后局部失败使用再照射(re-RT)的评估工作有限。我们回顾了我们在SSRS局部失败后采用常规分路外束辐射(cEBRT)进行挽救治疗的机构经验。材料和方法:我们对54例患者进行了回顾性研究,这些患者在先前接受过ssrs治疗的部位进行了补救性常规再rt。re-RT后的局部控制被定义为磁共振成像确定的治疗部位没有进展。结果:使用Fine-Gray模型进行局部失效的竞争风险分析。cEBRT - rt后的中位随访时间为25个月,中位总生存期(OS)为16个月(95%可信区间[CI], 10.8-24.9个月)。多变量Cox比例风险分析显示,重新rt治疗前Karnofsky表现评分(风险比[HR] = 0.95;95% ci, 0.93-0.98;p = 0.003)和局部故障发生时间(HR = 0.97;95% ci, 0.94-1.00;p = 0.04)与较长的生存期相关,而男性(HR = 3.92;95% ci, 1.64-9.33;p = 0.002)与较短的OS相关。12个月时局部控制率为81% (95% CI, 69.3-94.0)。竞争风险多变量回归显示放射耐药肿瘤(亚危险比[subHR] = 0.36;95% ci, 0.15-0.90;p = 0.028)和硬膜外疾病(subHR = 0.31;95% ci, 0.12-0.78;P =0.013)与局部衰竭风险增加相关。12个月时,91%的患者保持了行走功能。结论:我们的数据表明,在SSRS局部失效后使用cEBRT是安全有效的。在再治疗的情况下,需要进一步研究cEBRT的最佳患者选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.50
自引率
4.30%
发文量
24
期刊最新文献
Implementing high-dose rate surface mould brachytherapy for carcinoma of eyelid: a practical approach and weekly review The effects of high-dose radiation therapy on bone: a scoping review Validation of Combs prognostic scoring system in Indian recurrent glioma patients treated with re-radiation Long-term toxicities after allogeneic hematopoietic stem cell transplantation with or without total body irradiation: a population-based study in Korea Proton beam therapy as a promising option for high-risk limited stage small cell lung cancer: revealing potential of future novel agents
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1